Abdul Effendi MD in Roseville, Michigan

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Sorry, his university is not listed
Graduation Year: 1989
The Primary Medical Specialty for Abdul Effendi MD is listed as: Nephrology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 35
PAC (PECOS ID)#: 3870535248
NPI #: 1881647584
NPI Created On: 05/17/2006
NPI Last Updated Listed as: 10/18/2018
Primary Taxonomy Code: 207RN0300X
License Number:
058052
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• Molina Healthcare of Michigan, Inc.
• Humana
• Total Health Care USA, Inc.
• McLaren Health Plan Community
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Arabic.

Services and Procedures include:

1. Insertion of needle into vein for collection of blood sample
2. Hemoglobin a1c level
3. Vaccine for influenza for injection into muscle
4. Hemodialysis procedure with one physician evaluation
5. Dialysis services (4 or more physician visits per month), patient 20 years of age and older
6. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
7. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
8. New patient office or other outpatient visit, typically 30 minutes
9. New patient office or other outpatient visit, typically 45 minutes
10. Established patient office or other outpatient visit, typically 15 minutes
11. Established patient office or other outpatient, visit typically 25 minutes
12. Initial hospital inpatient care, typically 50 minutes per day
13. Initial hospital inpatient care, typically 70 minutes per day
14. Subsequent hospital inpatient care, typically 15 minutes per day
15. Subsequent hospital inpatient care, typically 25 minutes per day
16. Subsequent hospital inpatient care, typically 35 minutes per day
17. Prolonged inpatient or observation hospital service first hour
18. Physician telephone patient service, 11-20 minutes of medical discussion
19. Administration of influenza virus vaccine
20. Injection, ferric carboxymaltose, 1 mg